Thailand DHC Fertility Center Ranking Evaluation and Selection Guide

Table of Contents

Opening: Real consultation scenario

A 42-year-old female patient with an AMH of 1.2 ng/mL, carrying a history of two previous IVF failures, opened her phone in the consultation room and asked me: "This is a ranking of Thai fertility centers I saw online. DHC is ranked in the top five in Bangkok. Is it reliable? Should I choose based on this ranking?"

I encounter this question almost every week. Her confusion is very representative—when information is asymmetric, people tend to rely on a simple "ordering" to make major medical decisions. But the logic of choosing assisted reproduction is far more complex than a ranking.

Module A: Direct answer to the question

1. Direct Answer: Is there an official ranking for Thailand DHC Fertility Center?

There is no official institution in Thailand that publishes a ranking of fertility centers. Regulatory bodies such as the Thai Ministry of Public Health and the Medical Council only conduct qualification certification and practice licensing; they do not set up a "leaderboard." Currently, the "Thailand fertility center rankings" and "Bangkok IVF hospital rankings" found online mainly come from:

• Commercial medical intermediary websites: Sorted by the number of partner institutions, user reviews, paid promotions, etc., not medical evaluation.
• Self-media/personal experience posts: The sample size is extremely small, and patients' ages, causes, and treatment cycles differ, making results incomparable horizontally.
• Some overseas platform ratings: Such as Google Maps and Facebook ratings, which reflect service experience (language communication, waiting time, environment, etc.), not clinical capability.

Therefore, the so-called "DHC ranking number" cannot be verified and should not be the core basis for selection. DHC (Deep & Harmony Clinic) is a medium-sized private fertility center in Bangkok. It has its own characteristics in genetic counseling, PGT technology application, and personalized ovulation induction protocols, but "ranking" itself is a false proposition.

Module C: How doctors view it

2. How do doctors view "rankings"?

As a reproductive doctor, when evaluating whether a center is reliable, I usually don't look at any leaderboard but focus on several hard indicators not influenced by marketing:

2.1 Embryology lab level and stability

The lab is the "heart" of a fertility center. Does DHC's lab meet the following conditions:

• Does it have an independent embryology team, rather than shared lab personnel;
• Does it have stable incubators, air purification systems, and real-time monitoring systems;
• Is PGT (Preimplantation Genetic Testing) performed in-house or outsourced to a third party.

Lab quality directly affects the blastocyst formation rate and chromosome normalcy rate. This is far more important than "ranking."

2.2 Seniority and expertise of the primary physician

What is the background of DHC's founding doctors and primary team? Are they specialized in reproductive endocrinology, or more focused on genetics? Different doctors have different areas of expertise:

• Some doctors are experienced in ovulation induction for patients with poor ovarian response;
• Some doctors are better at managing recurrent implantation failure;
• Some doctors have deep experience in PGT-A/PGT-M (single gene disorder testing).

Whether the doctor's expertise matches your situation is more valuable than any ranking.

2.3 Transparency of the treatment process

A responsible center will clearly inform you of:

• The cost breakdown for each step (medication, surgery, lab fees, PGT fees, etc.);
• The rationale and expected outcomes of different ovulation induction protocols;
• How embryo results are communicated (whether embryo photos and grading reports are provided).

If the process is not transparent, or if there are excessive promises (like "guaranteed success" or "100% success"), it should not be chosen regardless of its ranking.

Module F: Differences between hospitals

3. Differences between DHC and other Thai fertility centers

Fertility centers in Bangkok, Thailand, can be roughly divided into three categories:

Category	Representative Centers	Features	Suitable For
Large chain/internationally renowned	BNH, Bumrungrad, Jetanin	Large scale, high volume of international patients, standardized processes, comprehensive Chinese language services	First-time attempts, those wanting convenience, high language communication needs
Medium-sized specialist/doctor brand	DHC, EK, Vejthani	Doctor-managed, personalized protocols, lab with specialized focus	Complex medical history, repeated failures, need for deep doctor involvement
Small boutique/specific technical focus	Some independent doctor clinics	Highly customized, appointment-based,注重 privacy	Specific technical needs (e.g., PGT, genetic disease prevention)

DHC belongs to the second category—a medium-sized specialist clinic. Its advantages lie in: a relatively stable doctor team, flexible protocol adjustments, and extensive experience in genetic counseling and PGT application. Disadvantages include: limited patient capacity, potentially longer appointment cycles during peak periods, and some tests needing to be sent to external labs.

Compared to large hospitals, DHC offers a higher degree of personalization but may have slightly weaker process standardization. This is neither good nor bad; it depends on what the patient values more.

Module G: The most easily overlooked details

4. The most easily overlooked evaluation details

When consulting DHC or other Thai fertility centers, the following details are often overlooked but significantly impact the treatment experience and outcome:

• Does the doctor personally perform ultrasounds and egg retrieval?: In some centers, monitoring is done by nurses or sonographers, and the doctor only appears on the day of retrieval. At DHC, the primary doctor is usually responsible throughout, but this needs confirmation.
• Is embryo culture done on Day 3 or Day 5/6?: Is the center willing to provide internal data (rather than citing literature) on blastocyst culture rates, freeze-thaw survival rates, etc.?
• PGT biopsy timing and testing platform: Is it Day 5 trophectoderm biopsy or Day 3 blastomere biopsy? Is NGS or aCGH used? Different platforms have different resolutions.
• Luteal phase support protocol: Is it oral, vaginal gel, or injection? Different protocols greatly affect patient convenience and tolerance.
• Emergency management process: In case of OHSS (Ovarian Hyperstimulation Syndrome) or post-retrieval bleeding, does the center have an emergency referral hospital?

Module J: Timeline

5. General timeline for treatment at DHC

If you plan to undergo IVF/ICSI treatment at DHC, the timeline is roughly as follows (using a standard cycle as an example):

Stage	Time Required	Description
① Initial consultation and registration	1-2 weeks (online)	Submit previous test reports and medical records, conduct a remote consultation, determine the preliminary plan
② First visit to Thailand & supplementary tests	3-5 days	Complete missing tests (AMH, semen analysis, hysteroscopy, etc.), meet the doctor to confirm the plan
③ Ovarian stimulation phase	10-14 days	Monitor follicle development daily or every other day, adjust medication dosage
④ Egg retrieval surgery	1 day (rest 1 day post-op)	Performed under intravenous sedation, can be discharged after 2-3 hours of observation
⑤ Embryo culture & PGT	5-14 days (depending on test type)	Blastocyst culture 5-6 days, PGT-A about 7-10 days, PGT-M requires 4-6 weeks
⑥ Frozen embryo transfer	1 day (requires endometrial preparation cycle)	Usually scheduled for the 2nd or 3rd menstrual cycle after retrieval, requires starting endometrial preparation 10-14 days in advance

Note: If PGT-M (single gene disorder testing) is needed, a probe must be made first. This process usually takes 4-6 weeks and must be completed before starting ovarian stimulation. Therefore, the overall cycle will be longer for patients needing genetic disease prevention.

Recommended advance planning:

• Complete basic tests (AMH, semen, chromosomes, etc.) at least 3 months in advance;
• Passport must be valid for more than 6 months;
• If PGT-M is needed, probe preparation should start 2-3 months in advance.

Module L: Interpretation of examination indicators

6. Interpretation of key examination indicators

Before deciding whether to choose DHC or any center, the following indicators can help you assess whether your situation matches:

6.1 Female ovarian reserve indicators

• AMH (Anti-Müllerian Hormone): Reflects ovarian reserve. AMH < 1.0 ng/mL indicates diminished reserve, requiring individualized stimulation protocols. DHC has some experience in stimulating low responders, but a doctor's assessment is needed.
• FSH (Follicle-Stimulating Hormone): Basal FSH > 10 IU/L suggests potentially poor ovarian response.
• Antral Follicle Count (AFC): Total antral follicle count < 5-7 indicates low response risk.

6.2 Male examination indicators

• Semen analysis: Concentration, motility, morphology. Severe oligoasthenoteratozoospermia may require ICSI or testicular sperm extraction.
• Sperm DNA Fragmentation Index (DFI): DFI > 30% may affect embryo developmental potential and implantation rate.

6.3 Chromosomal and genetic indicators

• Karyotype of both partners: To rule out structural abnormalities like balanced translocations, Robertsonian translocations.
• Carrier screening for single gene disorders: Choose a screening panel based on ethnicity and family history.

These indicators help determine whether DHC's PGT technology and genetic counseling capabilities can address your core issues. If the main problem is poor ovarian reserve, then the lab's embryo culture level and the doctor's stimulation experience are more important than PGT capability.

Module Q: Frequently asked questions

7. Frequently asked questions

Below are the most common questions encountered during consultations about DHC, answered collectively:

7.1 Can I still do IVF at DHC with low AMH?

Yes, but expectations need to be managed. Low AMH doesn't mean you can't get pregnant, but the number of eggs retrieved may be low (usually < 5 per cycle). DHC has some experience with mild stimulation and natural cycle protocols, but it's advisable to discuss expected egg numbers and blastocyst formation rates with the doctor in advance. If AMH < 0.5 ng/mL, an egg or embryo accumulation strategy may be needed.

7.2 How far in advance should I prepare for IVF in Thailand?

Basic tests (AMH, semen, chromosomes, infectious disease screening) should be completed 3 months in advance. Your passport must be valid for more than 6 months. If PGT-M is involved, probe preparation requires an additional 2-3 months. Visas can usually be processed 1-2 months in advance.

7.3 How many times must the male partner travel for overseas IVF?

Usually at least 2 times: the first time for the initial visit to complete semen analysis and registration; the second time for sperm collection on the day of egg retrieval. If using frozen sperm, it can be cryopreserved in advance, but DHC's frozen sperm procedures and transport conditions need to be confirmed.

7.4 Is PGT-A necessary at DHC?

PGT-A is suitable for: female age ≥ 38, recurrent implantation failure, recurrent miscarriage, or a history of chromosomally abnormal embryos. For young patients with no adverse pregnancy history, PGT-A is not routinely recommended. DHC has experience in PGT, but the indication requires individualized doctor judgment.

7.5 What documents are needed?

• Passport (validity > 6 months);
• Marriage certificate (some centers require translation and notarization);
• All previous test reports and medical records (translated copies);
• If genetic testing is needed, the proband's (patient's) genetic report.

Module R: Practitioner observations

8. Practitioner observations and reminders

Having worked in the assisted reproduction industry for over a decade, I have witnessed the choices of thousands of families. Regarding "rankings" and "choosing a center," here are some real observations:

• Rankings are fluid, but a doctor's experience is accumulated. An embryologist who has worked at DHC for 8 years is more trustworthy than a "top-ranked" center with high staff turnover.
• Don't underestimate "communication costs". Some centers, though not highly ranked, have doctors willing to spend 40 minutes discussing protocol details with you. This communication greatly impacts treatment confidence and compliance. Whether DHC's Chinese service team is professional and whether the doctor communicates personally needs to be experienced firsthand.
• In failed cases, the most common reason is not "a bad center" but "a mismatch". For example, a patient with normal ovarian reserve goes to a center specializing in mild stimulation, or a patient with genetic disease needs goes to a center with insufficient PGT experience.
• Beware of excessive promises. Any center that promises "guaranteed success" or "90% success rate," regardless of its ranking, should be placed on a watch list. Real success rates need to be stratified by age, cause, and medical history, and are limited by statistical sample size.

Ending: Doctor's advice